389 related articles for article (PubMed ID: 22560689)
1. Imaging of pancreatic adenocarcinoma: update on staging/resectability.
Tamm EP; Balachandran A; Bhosale PR; Katz MH; Fleming JB; Lee JH; Varadhachary GR
Radiol Clin North Am; 2012 May; 50(3):407-28. PubMed ID: 22560689
[TBL] [Abstract][Full Text] [Related]
2. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
3. Radiology of pancreatic adenocarcinoma: current status of imaging.
Sahani DV; Shah ZK; Catalano OA; Boland GW; Brugge WR
J Gastroenterol Hepatol; 2008 Jan; 23(1):23-33. PubMed ID: 18171340
[TBL] [Abstract][Full Text] [Related]
4. Defining venous involvement in borderline resectable pancreatic cancer.
Chun YS; Milestone BN; Watson JC; Cohen SJ; Burtness B; Engstrom PF; Haluszka O; Tokar JL; Hall MJ; Denlinger CS; Astsaturov I; Hoffman JP
Ann Surg Oncol; 2010 Nov; 17(11):2832-8. PubMed ID: 20725860
[TBL] [Abstract][Full Text] [Related]
5. Multimodality staging optimizes resectability in patients with pancreatic and ampullary cancer.
Awad SS; Colletti L; Mulholland M; Knol J; Rothman ED; Scheiman J; Eckhauser FE
Am Surg; 1997 Jul; 63(7):634-8. PubMed ID: 9202539
[TBL] [Abstract][Full Text] [Related]
6. Poorly enhanced areas of pancreatic adenocarcinomas on late-phase dynamic computed tomography: comparison with pathological findings.
Hattori Y; Gabata T; Zen Y; Mochizuki K; Kitagawa H; Matsui O
Pancreas; 2010 Nov; 39(8):1263-70. PubMed ID: 20467344
[TBL] [Abstract][Full Text] [Related]
7. [Preoperative staging of pancreatic adenocarcinoma: a practice survey of French gastroenterologists and digestive surgeons. Ordering of supplemental examinations and preoperative criteria of loco-regional spread].
Lévy P; Boudet MJ; Zins M; Gayet B
Gastroenterol Clin Biol; 1999 Oct; 23(10):1055-61. PubMed ID: 10592878
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and treatment of pancreatic and ampullary cancer.
Murr MM; Oishi AJ; Toma TP; Sarr MG
J Med Liban; 1995; 43(4):200-7. PubMed ID: 8885553
[No Abstract] [Full Text] [Related]
9. Identification of patients with resectable pancreatic cancer: at what stage are we?
Gorelick AB; Scheiman JM; Fendrick AM
Am J Gastroenterol; 1998 Oct; 93(10):1995-6. PubMed ID: 9772077
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic adenocarcinoma: CT versus MR imaging in the evaluation of resectability--report of the Radiology Diagnostic Oncology Group.
Megibow AJ; Zhou XH; Rotterdam H; Francis IR; Zerhouni EA; Balfe DM; Weinreb JC; Aisen A; Kuhlman J; Heiken JP
Radiology; 1995 May; 195(2):327-32. PubMed ID: 7724748
[TBL] [Abstract][Full Text] [Related]
11. [Retroactive evaluation of perioperative staging and surgical decision making for patients with pancreatic cancer].
Wang CY
Zhonghua Wai Ke Za Zhi; 2007 Jan; 45(1):3-5. PubMed ID: 17403279
[No Abstract] [Full Text] [Related]
12. Prediction of vascular involvement and resectability by multidetector-row CT versus MR imaging with MR angiography in patients who underwent surgery for resection of pancreatic ductal adenocarcinoma.
Lee JK; Kim AY; Kim PN; Lee MG; Ha HK
Eur J Radiol; 2010 Feb; 73(2):310-6. PubMed ID: 19070981
[TBL] [Abstract][Full Text] [Related]
13. Endoscopic evaluation and palliation of pancreatic adenocarcinoma: current and future options.
Pausawasdi N; Scheiman J
Curr Opin Gastroenterol; 2007 Sep; 23(5):515-21. PubMed ID: 17762557
[TBL] [Abstract][Full Text] [Related]
14. State-of-the-art magnetic resonance imaging of pancreatic cancer.
Schima W; Ba-Ssalamah A; Goetzinger P; Scharitzer M; Koelblinger C
Top Magn Reson Imaging; 2007 Dec; 18(6):421-9. PubMed ID: 18303400
[TBL] [Abstract][Full Text] [Related]
15. Staging of pancreatic adenocarcinoma by imaging studies.
Wong JC; Lu DS
Clin Gastroenterol Hepatol; 2008 Dec; 6(12):1301-8. PubMed ID: 18948228
[TBL] [Abstract][Full Text] [Related]
16. Role of imaging in the management of pancreatic mass.
Peddu P; Quaglia A; Kane PA; Karani JB
Crit Rev Oncol Hematol; 2009 Apr; 70(1):12-23. PubMed ID: 18951813
[TBL] [Abstract][Full Text] [Related]
17. Contrast-enhanced 18F-FDG PET/CT: 1-stop-shop imaging for assessing the resectability of pancreatic cancer.
Strobel K; Heinrich S; Bhure U; Soyka J; Veit-Haibach P; Pestalozzi BC; Clavien PA; Hany TF
J Nucl Med; 2008 Sep; 49(9):1408-13. PubMed ID: 18703604
[TBL] [Abstract][Full Text] [Related]
18. Downstaging chemotherapy and alteration in the classic computed tomography/magnetic resonance imaging signs of vascular involvement in patients with pancreaticobiliary malignant tumors: influence on patient selection for surgery.
Donahue TR; Isacoff WH; Hines OJ; Tomlinson JS; Farrell JJ; Bhat YM; Garon E; Clerkin B; Reber HA
Arch Surg; 2011 Jul; 146(7):836-43. PubMed ID: 21768431
[TBL] [Abstract][Full Text] [Related]
19. Role of endoscopic ultrasound and magnetic resonance imaging in the preoperative staging of pancreatic adenocarcinoma.
Ahmad NA; Lewis JD; Siegelman ES; Rosato EF; Ginsberg GG; Kochman ML
Am J Gastroenterol; 2000 Aug; 95(8):1926-31. PubMed ID: 10950037
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic cancer: current concepts in imaging for diagnosis and staging.
Tamm E; Charnsangavej C
Cancer J; 2001; 7(4):298-311. PubMed ID: 11561606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
